ORLANDO -- More than 80% of patients with moderate or severe atopic dermatitis (AD) had at least 75% improvement after 12 ...
The Food and Drug Administration said several lots of six products containing benzoyl peroxide are being recalled, including ...
Dyne Therapeutics’ DYNE-101 shows positive results in phase 1/2 ACHIEVE study. Read why DYN stock may rise with FDA approval and a $2.78B market opportunity.
Mobile medication units will bring help for opioid addiction to underserved areas. The program needs more state support.
Announced positive data from Phase 1 clinical trial evaluating VG-3927 for potential treatment of Alzheimer’s Disease (AD); plans to initiate ...
AC Immune Reports Full Year 2024 Financial Results and Provides a Corporate UpdateLandmark exclusive option and license deal with Takeda for ...
Mark Millich, 26 years old and insecure about his thinning hair, was curious about the ads he saw promising to reverse his ...
Rehabilitation centers must prioritize online visibility. An effective online presence can enhance engagement with potential ...
19h
Discover Magazine on MSNRosemary and Sage Could Lead to Better Alzheimer's TreatmentDiscover how a natural compound found in these common herbs could enhance cognitive function and ease inflammation.
The SXSW documentary 'Shuffle,' directed by Benjamin Flaherty, reveals how rehab facilties prey on addicts for the sake of ...
The Substance Abuse and Mental Health Services Administration has already closed offices and could see staff numbers reduced ...
The third-place slot marked another return to form. Novo Nordisk’s Wegovy reclaimed the seat it held in December, backed by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results